6:41 AM
Registration & Continential Breakfast Opens for Participants of Closed-Door Roundtable
8:00 AM
Invitation-Only C-Suite Breakfast Roundtable Sponsored by:
Mobile Health Solutions and Cloud Based Systems that Deliver Meaningful Patient Engagement

Mobile health technology (mHealth) and cloud based systems are rapidly changing the way physicians monitor and communicate with patients. In this informal breakfast roundtable participants discuss:
  • Virtual Collaboration & Patient Monitoring - How are physicians using mobile technology to monitor remotely and deliver care to patients? How are patients using apps to manage conditions and communicate with physicians?
  • Patient Education - How can apps be used for preventative care and education? We know about the quantified self-movement - what about for chronically ill patients?
  • Business Collaboration/Partnerships to accelerate innovation - How do you make them happen even if you are a smaller/less resourced health system?
  • Cloud based systems that enable secure mobility and facilitate physician and patient adoption

Azeem Mohamed

CTO, HP Software Alliances and Channel
HP
6:41 AM
Registration & Continental Breakfast Opens for General Delegation
6:41 AM
Welcome from Information Management Network (IMN)
6:41 AM
Welcome from Conference Co-Chairs

Sameer Badlani

Chief Health Information Officer
Intermountain Healthcare

Mohan Putcha

Chief Technology Officer
University of Chicago Medical Center and Biological Sciences
9:00 AM
Crossing the Chasm - Moving From Data Capture to Meaningful Improvements in Patient Care and Clinical Efficiency
Knee deep in the implementation of an EHR system it can be easy to forget the end goal. In this session, learn what is necessary to realize the vision of improved quality, safety and efficiency, engaged patients and families, improved care coordination, better public and population health, all the while ensuring the privacy and security of personal health information.
  • Achieving broad based EHR implementation, physician adoption, and system interoperability
  • The use of cloud based software and systems to control costs, improve scalability and create a secure environment for patient and physician collaboration
  • Building or securing the analytic infrastructure to make use of the data in a meaningful way
  • As we move towards a value based system how will technology enable health systems/clinicians to practice effective population health management?

Michael Millenson

President
Health Quality Advisors

Fred Rachman

Chief Executive Officer
Alliance of Chicago

Rasu Shrestha

Vice President, Medical Information Technology, Medical Director, Interoperability and Imaging Informatics
University of Pittsburgh Medical Center

William Hudson

Senior Business Strategist
VMWare
6:41 AM
The Silver Lining - What Cloud Based Services Mean for Collaboration, System Evolution and Population Health Management

The Healthcare System IT department can be one of a constant state of catch-up or you can try to get ahead. Meeting new regulatory requirements, evolving business needs and benefiting from the latest technology means the CIOs job is never done. In such a fast moving environment, how can a CIO stay ahead of the ever increasing and changing demands. In this panel, experts discuss resource management and how cloud based services can ease the constant churn in the IT department and help a health system be ready to deal with changing demands of patients and regulators.

  • Can cloud based services help avoid costly software upgrades and associated costs training physicians to use updated systems?
  • Can cloud based systems provide an easy framework for patient engagement and population health management?
  • How can systems bridge the gap between cloud based academic or industry research and clinical practice?
  • Technologies expected to emerge within the next five years, and how can you best prepare for eventual adoption?
  • Look to the future What should every CIO prepare for now and how can cloud based systems help?

Ralph Reyes

Chief Executive Officer & President, HCSage Consulting, Senior Advisor
AHA Healthcare Solutions, An American Hospital Association Company

Scott Holbrook

Strategic Advisor
Health Catalyst

Dan Gonos

Chief Technologist/HP Fellow
HP

Robert Grossman

Chief Research Informatics Officer, Division of Biological Sciences
University of Chicago

David Goldsteen

Chief Executive Officer
VigiLanz Corporation
6:41 AM
Networking Break Courtesy of:

Concurrent Sessions: Choose Track A or Track B Track A: Data Driven Care Management Predictive Analytics & Data Driven Clinical Decision Making Track B: Integrated and Interoperable Systems for Integrated Delivery
6:41 AM
Big Data - What is the Big Deal in Healthcare?
Big Data is a big buzzword that means different things to different people. The most accepted definition is that Big Data is a tool that enables complex analysis of vast volumes of a variety of data sources at a high velocity. Hence the three Vs coined by IBM are volume, variety and velocity. No doubt these vs exist in healthcare but some question if the industry is really ready for Big Data. In this session, expert discuss:
  • The promise versus the problems of Big Data applications in healthcare
  • Real applications of Big Data in healthcare currently being implemented
  • How their organizations are looking at Big Data and when and how they are using it

Gordon Heinrich

Executive Director - Big Data Analytics
Sandlot Solutions

Gary Fingerhut

Acting Executive Director and General Manager, IT Commercialization
Cleveland Clinic

John Chelico

Chief Medical Informatics Officer
North Shore University Hospital & Long Island Jewish Medical Center

Sameer Badlani

Chief Health Information Officer
Intermountain Healthcare
6:41 AM
ACOs the Evolving Healthcare Delivery Payment Models Impact on Clinical and Administrative Systems

The total of approved ACOs is now over 250. At their core, ACOs depend on clinical integration, care management and financial risk management for success. By linking provider reimbursement to quality metrics and cost control, ACOs are incentivized to provide quality care for less. In this session youll hear from leading ACO IT experts on how they are:

  • Implementing EHR that supports clinical integration
  • Using data management tools to improve clinical decision making
  • Depending on HIE for a better picture of the health of their populations
  • Opportunities and challenges with clinical and financial system integration

Anupam Goel

Vice President, Clinical Information
Advocate Health Care
6:41 AM
Leveraging Analytics in Every Day Clinical Operations

It is hard enough to get physicians to use EHR systems, some argue that adding a layer of analytical tools over the EHR will be too much. However if your system isnt using the data you are collecting then where is the return on implementing these multi-million dollars systems? In this session, one hospital details their experience integrating an analytic suite into everyday clinical operations.

  • Project ownership and working with other key stakeholders
  • Make the business case for predictive analytics
  • Identify high impact areas for research and projects
  • Set up the infrastructure to ensure clean quality data collection
  • Measure success and evaluate impact on outcomes

Steven Merahn

Senior Vice President, Clinical Programs
ActiveHealth Management

Nancy Garrett

Chief Analytics Officer
Hennepin County Medical Center

James Gaston

Senior Director, Clinical & Business Intelligence
HIMSS Analytics

Alan Snell

Chief Medical Informatics Officer
St. Vincent Health
6:41 AM
Real-Time Clinical Data: How Cloud-Based Dynamic Clinical Monitoring Improves Patient Safety, Care and Effectiveness

Hospital adoption of electronic health record systems has tripled since 2009 bringing with it a revolution in dynamic data and medical informatics. Real-time access of patient demographics, pharmaceutical orders, lab and microbiology values, among other real-time inputs, significantly increase patient safety, quality care and cost effectiveness. In this case study, leading visionary clinicians share the impact they are making on the front lines of real-time health care today, and the successful results theyve generated by reducing adverse drug events and health care acquired infections; improvements in core measure compliance; and cost effective antibiotic utilization.

- Connecting with the cloud to drive agilityand flexibility
- ROI scenarios with rapid payback
- Real-time patient care through dynamic data
- Automated workflows to enhance patient care and responsiveness

David Goldsteen

Chief Executive Officer
VigiLanz Corporation

John Russillo

Clinical Pharmacy Manager
John Muir Health
6:41 AM
Luncheon Sponsored by:
The Three Biggest Mistakes Health Systems Make when they Move to the Cloud

Keynote Speaker:
Scott Miller, Director of Data Center/Cloud Practice, WORLD WIDE TECHNOLOGY [ BIO ]

General Session
6:41 AM
Public Versus Private HIE – Determine the Value for your Health System and your Patients

According to the Chilmark Research report in May 2012, the bulk of health information exchange growth is now in privately sponsored, enterprise health information exchanges. In the push to meet meaningful requirements, some hospitals are finding it faster and quicker to go the private route, others are using a hybrid approach. In this session, HIE experts discuss the benefits and the options available to health systems in the Mid-West.

  • Understand where have HIEs been successful and why and how this should inform your health systems strategy
  • Evaluate the strengths and weaknesses of private run HIEs versus the traditional public/private exchanges
  • Choose the right systems and connect with the best vendors for your needs
  • Generate value from EHR data in the absence of system wide interoperability

Rod Piechowski

Senior Director, Health Information Systems
HIMSS

Raul Recarey

Executive Director
Illinois Health Information Exchange Authority

Harold Apple

Chief Executive Officer and President
Indiana Health Information Exchange

Charles Cox

Director, MetroChicago HIE
Metropolitan Chicago Healthcare Council (MCHC)

Marc Beasley

Director, MobileMD
Siemens
Concurrent Sessions: Choose Track A or Track B Track A: Analytics & Data Driven Clinical Decision Making Track B: IT Investments Driving Clinical and Operational Efficiency
6:41 AM
Case Study – Next Generation HIE and Analytics – Making Organization Level Population Health Management Achievable
Analytics are being used for a number of quality and efficiency improvement efforts--from reducing readmissions to treating patients at risk for stroke and cardiac arrest quickly and efficiently to reducing wait times, diversions and boarding in the emergency department. However, recent advances in information technology have accelerated significantly the benefits of HIE + analytics.

As a matter of necessity, ACOs around the country are launching with the technology in place to give physicians the ability to enjoy improved workflow, better access to information for improved coordination of individual patient care and tools for monitoring outcomes and population health management. In this case study, one nationally recognized ACOs discusses how theyve significantly improve outcomes and clinician satisfaction.
  • Give physicians more complete medical histories and the tools they need to improve care
  • Improve administrative workflow and clinician-to-patient communication, which leads to improved disease management and patient satisfaction
  • Support the coordination of individual patient care and monitors outcomes for overall population health management

Thomas Deas, Jr.

Gastroenterologist / Chief Medical Officer
North Texas Specialty Physicians / Sandlot Solutions

Joseph Casper

Chief Executive Officer
Sandlot Solutions
6:41 AM
Using Cloud Based Systems For Clinical and Non-Clinical Operations
In 2012, MarketsandMarkets reported that the healthcare cloud market would hit the $5 billion mark by 2017. Yet the industrys journey to the cloud has been slower than anticipated. Regulatory, security, and privacy concerns have been blamed, while others site the focus on MU requirements. In this session, experts discuss what health systems are using the cloud for including pharmacy and imaging use, physician order entry, EHR, claims management, cycle management, and billing. In addition, experts discuss hybrid and private clouds that deal with compliance and security concerns.
  • Employing cloud-related technologies like virtualization, storage
  • Exploration of novel platforms for clinical software enabled by emerging cloud technologies
  • Addressing security and compliance concerns for hybrid and public cloud based solutions

Scott Miller

Director, Business Development of Virtualization
World Wide Technology, Inc.

Jack Pressman

Director Strategic Planning, Dev. DC, Cloud Computing
Netrix, LLC

Keith Toussaint

Executive Director, Business Development, Global Business Solutions
Mayo Clinic

R. Chris Christy

Principal Healthcare
SAP Americas, Inc.
General Session
3:00 PM
Closing the Loop in Healthcare Analytics - Correlating Clinical and Administrative Systems with Research Efforts to Deliver Clinical Efficiency in Real Time

Up until now, health system analytics have provided a rear view mirror perspective on clinical and financial hospital operations while researchers use electronic health record data as a discovery tool. Now the capabilities are there to use analytics to improve care management, speed clinical advancements, and improve health system efficiency with advanced learnings that connect operational, clinical and research information, allowing for powerful analytics. In this session, experts discuss how health system executives can partner with their research organization to deliver better patient care.

In this session, youll hear from experts in the process of running small pilots and organization wide projects that:

  • Leverage data warehousing to perform advances predictive analytics to deliver operational insights
  • How to integrate diverse data (genomic, clinical, operational), from multiple sources, in a meaningful way
  • Preparing data to be used for research, including de-identification; quality improvement, personalized medicine
  • Break existing boundaries and address concerns about privacy and security

Mark Braunstein

Professor of the Practice, School of Interactive Computing, College of Computing, Associate Director for Health Systems, Institute for People and Technology
Georgia Institute of Technology

John Sharp

Manager, Research Informatics
Cleveland Clinic

Abel Kho

Co-Executive Director of CHITREC, Assistant Professor of Medicine, Associate Director of Medical Informatics Program
Northwestern University Feinberg School of Medicine

Mohan Putcha

Chief Technology Officer
University of Chicago Medical Center and Biological Sciences
6:41 AM
Networking Break Courtesy of:

4:00 PM
Putting New Technology and Data Initiatives into Auto Pilot
Provider organizations have invested significant resources into starting technology and data initiatives, such as EHR Meaningful Use. However, when new initiatives come along, such as ICD-10 transformation, often the same staff and resources allocated to run an existing initiative must be drawn upon to start new initiatives. Its key to learn how to put the organizations existing initiatives into "auto pilot" such that fewer staff and resources are needed to maintain existing initiatives than were needed when first implemented. Transforming staffing, processes, and tools to achieve auto-pilot mode frees up resources for other urgent priorities. The panel shares how they planned and executed the transition of their strategic technology and data initiatives from initial implementation into efficient parts of on-going operations.
  • Understand best practices towards re-balancing staff, tools, and resources to put data initiatives into auto pilot
  • Learn how organizational and environmental factors should influence choice of which best practices to apply
  • Exchange experiences and ideas with hands-on panelists who have led Meaningful Use, ICD-10, clinical integration, and other strategic initiatives from start to integration into regular operations

Thomas Lee

Founder and CEO
SA Ignite

Imran Khan

Manager - EHR, Meaningful Use and Patient-Centered Medical Home
Advocate Health Care

Terri Jacobsen

Senior Director, Corporate Administration
Cadence Health

Anibal Perez

Managing Consultant
Cumberland Consulting

Katie LeMoyne

ICD-10 Program Manager
Northwestern Memorial Hospital

Shannon Sims

Associate CMIO and Assistant Professor in Internal Medicine and Health Systems Management
Rush University Medical Center
5:00 PM
Networking Cocktail Reception with:

6:00 PM
Close of The Midwest Hospital Cloud Forum
My Agenda
Try out our new My Agenda feature.
Save sessions of interest, print for onsite use and insert to calendar for auto reminders.
NETWORK OPEN
Sign In
 
Contact Information
INFORMATION MANAGEMENT NETWORK
1120 Avenue of the Americas, 6th Floor
New York, NY 10036 USA


Phone: +1 (212) 901-0506
(8:30 AM - 5:30 PM Eastern Time / Monday-Friday)

E-mail: mail@imn.org


Event Specific Contacts for The Hospital Cloud Forum: From Meaningful Use to Meaningful Outcomes (Midwest)

TERMS AND CONDITIONS OF USE

Below are the terms and conditions governing your use of EIMN, LLC ("IMN") this website and any products or services connected therewith. By using the website or services connected with the website, you acknowledge and agree to the following:

*Your Obligations. You represent and warrant that you have the capacity to agree to these Terms and you are at least eighteen (18) years of age. To the extent any individual accesses a Site or uses a Service as an employee, partner, director, agent or representative ("Agent") of any legal entity which is a Subscriber, the Agent warrants that he or she has authority to agree to these Terms on behalf of the relevant legal entity.

You will procure that you and any licensed user under your subscription will: (a) comply with all applicable laws in relation to the site and services, including without limitation, laws relating to the use of Intellectual Property; (b) not use the site or the content outside the scope of permitted use and will not infringe any Intellectual Property or other rights in or relating to the site or the services or of any third party; (c) not copy, reproduce, recompile, decompile, disassemble, reverse engineer, upload, download, transmit, create derivative works from or otherwise exploit or tamper with the site or any software embodied in any site or service; (d) not prevent or restrict the use of any site or service by other authorized users nor hack into or cause damage to any server or other equipment operated by us; and (e) comply fully with these Terms.

*No IMN Warranties or Representations. IMN makes no warranty, express or implied, concerning any use of this website or any service or product provided in connection with this website. The services and products provided by IMN are provided on an "AS IS" basis. IMN disclaims any implied warranty of merchantability or fitness for a particular purpose, including any warranty for the use or the results of the use of the products or services. IMN is not responsible for correcting, maintaining or updating the data and services made available on this website.

Any material and analysis provided by or through IMN or this website is not a recommendation that must be followed or an offer, or solicitation of an offer to buy or sell any financial product; IMN does not recommend that you enter into a particular transaction or represent that any product or service described on this website is suitable for you or your company. Nor is any information displayed here promoting any particular financial product, service or trading strategy in any jurisdiction where such an offer or solicitation, or trading strategy may be prohibited. As all prudent investors know, some transactions, including but without limitation, those involving high-yield securities, give rise to substantial risk and any investment decision you may make is your own. You should not enter into any transactions unless you have fully understood all such risks and have independently determined that such transactions are appropriate for you. Any discussion of the risks contained herein with respect to any product should not be considered to be a disclosure of all risks or complete discussion of the risks mentioned.

*Restricted Use. As a user of this website, you are not permitted to display, modify, copy, print or otherwise use the information made available to you here only for your own use. You are not permitted to publish, transmit, or otherwise make this information available in any format to any third party without the prior express written consent of IMN. You also are not permitted to change or remove any copyright (©), trademark (®, SM, TM) any other notices displayed with the information. IMN can modify the information at any time and for any reason at its sole discretion. Unless expressly stated otherwise herein, no rights are granted to you regarding the information on this website from IMN or any other source, including third party providers of information for this website, which shall under no circumstances be liable to you in any way.

*IMN Monitoring. Your use of the products and services on this Web site may be monitored by IMN in any lawful manner, and that the resulting information may be used by IMN for its internal business purposes or in accordance with the rules of any applicable regulatory or self-regulatory organization.

*Website or Internet failure. IMN shall have no liability, contingent or otherwise, to you or to third parties, or any responsibility whatsoever, for the failure of any connection or communication service to provide or maintain your access to this service, or for any interruption or disruption of such access or any erroneous communication between IMN and you. IMN also does not warrant or represent that the website shall be completely secure, specifically including without limitation, that no unauthorized person shall intercept or access information transmitted by you.

*Website Access. Access to this website is restricted by password and only authorized IMN registrants may use the website. Any unauthorized access shall be the responsibility of the Registrant and his or her company and IMN shall not be liable for any damages arising out of such unauthorized access. You agree to: (1) Keep your password confidential; (2) prohibit others from using your account; (3) refrain from using other Users’ accounts; (4) refrain from selling, trading, or otherwise transferring your account to another party; and (5) refrain from charging anyone for access to any portion of DirectConnect, or any information arising therefrom. You are also responsible for anything that happens through your account unless you can demonstrate that your account was accessed without your knowledge or fault.

*User Communication. To the extent permitted while using DirectConnect, you can use and participate in groups, free to post and delete comment on the website. You are solely responsible for your interactions with other users. IMN may limit the number of connections you may have to other users and may at its sole discretion prohibit you from contacting other users through use of the Services or otherwise limit your use of the Services.

If you violate this Agreement while posting, that content may be removed without further notice or the rights of others posting here. Nothing you post here is confidential or proprietary and you are cautioned that other posters or viewers may use any information posted here. By posting here you agree that IMN is not responsible for the misappropriation or misuse of any information posted on this website.

*Privacy. Any submissions, including private personal information, like names, addresses and so on, are voluntary and you waive any and all rights you have to the protection of that information. By submitting ideas, suggestions, documents or other matter ("Submissions"), you agree that: (a) the Submissions are not confidential or proprietary information; (b) IMN has no obligation to keep the submissions confidential; (c) IMN can use or disclose the Submissions for any purpose, in any way, in any media worldwide; (d) if asked, you will irrevocably assign to IMN all rights to your Submissions; and (f) you are not entitled to any compensation of any kind from IMN under any circumstances.

*Content by Becoming a User of DirectConnect: As part of obtaining registration access to DirectConnect, unless you opt out, you may receive invitations to network from other conference attendees. We may also send you emails to keep you updated on developments in the site and services. Your registration for and/or subscription to such an email service and your use of the content received through these email services will be subject to these terms. You can unsubscribe to our email service by changing your email preferences on the website.

*License. If you comply with all your obligations under this Agreement, IMN grants you a limited, revocable, nonexclusive license and right to access the Services, through a generally available web browser, mobile device or application view information and use the web pages and in accordance with this Agreement for your use only. Any other use of DirectConnect is strictly prohibited. All rights not expressly granted in this Agreement, including, without limitation, title, ownership, intellectual property rights, and all other rights are retained by IMN.

*Anti-Hacking. You expressly agree not to use or attempt to use any "virus," "spyware," "malware," "adware," "Trojan horse" "deep-link," "scraper," "bot," "spider," "data-mining," "computer code" or any other automated device, program, tool, algorithm, process, or methodology or manual process having similar processes or functionality, to access, acquire, copy, or monitor any portion of this website or content. You also agree not to obtain or attempt to obtain through any means any materials or information on the website that have not been intentionally made available either by their public display on the Web Site or through their accessibility by a visible link or portal. You further agree not to violate the security of the website or attempt to gain unauthorized access to the website, data, materials, information, computer systems or networks connected to any server, through hacking, password mining or any other method.

*No Linkage. You expressly agree not to link or attempt to link to this website or the web pages contained herein.

*Third Party Information. Some of the information you access here is the property of third parties, made available here with the express permission of those third parties. IMN is not responsible for the content of any third party information provided on this website. You are cautioned that any further use of that information by you may be subject to the rights of those third parties and you may be required to obtain a license to use any such information. Failure to obtain third party permission may be a violation of federal law. You should contact the third party provider of the information to ascertain the requirements for using the information.

*Copyright and Trademarks. The layout of the website pages, graphics and pictures used and the collection of individual contributions are protected by copyright. All copyrights belong either to IMN, the third-party content providers or both. Either IMN or the third-party content providers own all trademarks and service marks depicted here.

*Indemnification. You agree to indemnify hold harmless and defend IMN, including our employees, officers, agents and contractors and our related entities and their employees, officers, partners, agents and contractors ("Indemnified") and continue to keep the Indemnified indemnified from and against any actions, proceedings, claims, demands, costs (on a full indemnity basis including, without limitation, reasonable legal and accounting fees) brought or made against the Indemnified by any person arising in connection with your use of the Website or content, or a breach of your representations and warranties in the Terms and Conditions of Use or this Agreement, or your violation of any of the Terms and Conditions of Use or this Agreement or any other activity in which you engage on or through, and from and against any damage, loss(whether personal or property, and whether direct or consequential, including without limitation consequential financial loss), cost or expense suffered or incurred by any Indemnified as a direct or indirect consequence thereof.

*Changes in Terms and Conditions. IMN may at any time revise the terms and conditions by which you may access the website or use IMN products or services. By using this website and IMN products and services, you agree to be bound by any such revisions and should therefore periodically visit this page to determine the then current version of this document.

*Limitation of Liability. Neither we, nor any of our suppliers, officers, employees, partners, affiliates, subsidiaries, successors and assigns, agents or representatives (our "Representatives") will be liable to you for:

(a) any incidental, punitive, indirect, special or consequential damage, loss or expenses, including but not limited to any loss of business, contracts, revenue, or profits, any business interruption, security breach, loss of data, loss of goodwill or reputation or other pecuniary loss suffered by you, even if we or any of our Representatives have been advised of their possible existence; nor? (b) any direct damage loss or expenses arising from loss of customers, loss of profits, loss of anticipated profits or loss of savings.

*Termination. You may terminate this Agreement, for any or no reason, at any time, when IMN receives notice from you. IMN may terminate the Agreement and your account for any reason or no reason, at any time, with or without notice. This cancellation shall be effective immediately or as may be specified in the notice and may include disabling your current and future access to DirectConnect. IMN may also suspend or terminate this Agreement if you invite other users with whom you do not know to connect; abuse the any DirectConnect messaging services; creating multiple or false profiles; infringe on any intellectual property rights, violating any provisions in this Agreement, disparage IMN or its executives, Board members, affiliates, staff or other related entities or persons, or exhibit any other behavior that IMN, in its sole discretion, deems contrary to the purpose of the website.

*No Waiver. Failure by either party to exercise any right or remedy under these Terms does not constitute a waiver of that right or remedy.

*Entire Agreement. These terms (including any terms incorporated by reference in these terms), constitute the entire agreement between you and us with respect to your access to and use of the website or receipt of any service and supersede all prior agreements, negotiations and discussions between you and us relating to the same.

*Law and Jurisdiction. Where you visit, register and/or subscribe to a this site or related service (as indicated on this website or otherwise notified to you), these terms (and any dispute or claim arising out of or in connection with these terms, including non-contractual disputes or claims), to the maximum extent permissible under the law of the territory that you are located in, will be governed by the laws of the State of New York. Any action to enforce these terms shall be brought in a federal court or a state court located in the state of New York, county of New York, and you agree to submit yourself to the personal jurisdiction of those courts in any such action.

*Force Majeure. We shall not be deemed to be in breach of these Terms by reason of any delay in performing, or any failure to perform any service or our obligations in relation to these Terms, if the delay or failure was due to any cause beyond our reasonable control, including but not limited to acts of God, explosions, floods, fire or accident, war or threat of war, terrorism or threat of terrorism, sabotage, civil disturbance, epidemics, prohibitions or measures of any kind on the part of any governmental, parliamentary or local authority, import or export regulations or embargoes, or industrial actions or trade disputes (whether involving our employees or of third parties).

*Severability. If any provision of these Terms is found to be wholly or partially invalid, void or unenforceable by any court having competent jurisdiction or by virtue of any legislation or any other reason, that provision shall be invalid, void or unenforceable to that extent only and no further and the validity and enforceability of the remaining provisions of these Terms shall not be affected.

*Notices. Any notice given pursuant to these Terms shall be made by email or first class post, in the case of you, to the address provided on your registration form and, in the case of us, to the address posted on the website or otherwise notified to you in relation to any relevant service. Any such notice shall be deemed to have arrived if sent by post within three (3) days of posting and if sent by email at the time of transmission.

PRIVACY STATEMENT

Our Privacy Commitments

Euromoney Institutional Investor PLC and Institutional Investor Inc. (together "we") respect the privacy of every person who visits, registers with or subscribes to our websites and online publications ("you"), and are committed to ensuring a safe online experience.
This Privacy Statement outlines the information we may collect about you in relation to your use of our websites and related publications and services ("personal data") and how we may use that personal data. It also outlines the methods by which we and our service providers may (subject to necessary consents) monitor your online behaviour in order to deliver customised advertisements and marketing materials and other tailored services. This Privacy Statement also tells you how you can verify the accuracy of your personal data and how you can request that we delete or update it.

This Privacy Statement applies to all websites operated by us (as indicated on the relevant website) ("Sites"). For the purpose of this Privacy Statement "group company" shall mean Euromoney Institutional Investor plc and any of its subsidiary companies, including, without limitation, Institutional Investor Inc. Please note that the Sites may contain links to external sites and may contain advertisements for, and/or the opportunity for you to purchase products or services from third parties. This privacy statement does not cover the activities of such third parties, and you should consult those third party sites' privacy policies for information on how your data is used by them.
By accessing and using the Sites you are agreeing to the terms of this Privacy Statement.

Information about us

Our principal business activities are:

  • Business-to-Business Financial Publishing. We provide a range of products and services focused on international finance, metals, commodities, telecoms and emerging markets including magazines, newsletters, electronic information and data
  • Organisers of Seminars, Conferences, Training Courses and Exhibitions for the financial markets industry

Euromoney Institutional Investor plc Company Address:

Nestor House,
Playhouse Yard,
London EC4V 5EX
United Kingdom

Institutional Investor, Inc. Company Address:

1120 Ave of the Americas, 6th floor
New York, NY 10036
USA

Name of the Data Controller

The Data Controllers are Euromoney Institutional Investor plc and Institutional Investor Inc.
Euromoney Institutional Investor plc is subject to the UK Data Protection Act 1998 and is registered in the UK with the Information Commissioner's Office.

Collection of Personal Data

Our primary goal in collecting personal data from you is to give you an enjoyable customised experience whilst allowing us to provide services and features that most likely meet your needs.

We collect certain personal data from you, which you give to us when using our Sites and/or registering or subscribing for our products and services. However, we also give you the option to access our Sites' home pages without subscribing or registering or disclosing your personal data.

We also collect certain personal data from other group companies to whom you have given information through their websites (including, by way of example, Euromoney Institutional Investor plc and Institutional Investor Inc, in accordance with the purposes listed below).
Please note that we do not intend to collect any personal data from children under thirteen years of age and no child under thirteen should submit any personal data to any of the Sites. Should we discover that any such personal data has been delivered to any of the Sites, we will remove that information as soon as possible.

Types of Personal Data Held and its Use

  1. Customer Services and Administration

At some Sites, Euromoney collects personal data such as your name, job title, work and/or home address, and telephone number and email address in order to register you for access to certain content and subscriptions. This information may be supplemented with demographic information from your use of our Sites such as your postal area, age, gender, purchasing preferences and interests.

At other Sites, Euromoney may only collect broad demographic information for aggregate use.

This information is used to administer and deliver to you the products and/or services you have requested, to operate our Sites efficiently and improve our service to you, and to retain records of our business transactions and communications. By using the Sites and submitting personal information through the registration process you are agreeing that we may collect, hold, process and use your information (including personal information) for the purpose of providing you with the Site services and developing our business, which shall include (without limitation) the purposes described below in paragraphs 2 and 3.

  1. Monitoring use of our Sites

Where, as part of our Site services, we enable you to post information or materials on our Site, we may access and monitor any information which you upload or input, including in any password-protected sections. Subject to any necessary consents, we also monitor and/or record the different Sites you visit and actions taken on those Sites, e.g. content viewed or searched for. If you are a registered user (e.g. a subscriber or taking a trial), when you log on, this places a cookie on your machine. This enables your access to content and services that are not publicly available. Once you are logged on, the actions you take - for example, viewing an article - will be recorded (subject to any necessary consents). We may use technology or a service provider to do this for us. This information may be used for one or more of the following purposes:

    • to fulfil our obligations to you;
    • to improve the efficiency, quality and design of our Sites and services;
    • to see which articles, features and services are most read and used
    • to track compliance with our terms and conditions of use, e.g. to ensure that you are acting within the scope of your user licence;
    • for marketing purposes (subject to your rights to opt-in and opt-out of receiving certain marketing communications) - see paragraph 3 below;
    • for advertising purposes, although the information used for these purposes does not identify you personally. Please see paragraph 5 below for more details;
    • to protect or comply with our legal rights and obligations; and
    • to enable our journalists to contact and interact with you online in connection with any content you may post to our Sites.

Please see paragraph 5 below for more information on cookies and similar technologies and a link to a page where you can turn them on or off.

  1. Marketing:

Some of your personal data collected under paragraphs 1 and 2 above may be used by us and/or our other group companies and third party service providers to contact you by email, fax, telephone and/or post for sending information or promotional material on our products and/or services and/or those of our other group companies.
We give you the opportunity to opt-out of receiving marketing communications and will in certain circumstances need to obtain your consent before sending such communications to you. Further detail can be found on the applicable Site and in each marketing communication sent by us, our group companies or service providers. See also "Consents and opt-outs" section below.

  1. Trading in Personal Data:

Some of your personal data may be collected and processed with the intention of selling it to other organisations, but this will not be done unless you have given your consent (separately to this privacy statement).

  1. Cookies and similar technologies

All our Sites use cookies and similar technical tools to collect information about your access to the Site and the services we provide.

Cookies are pieces of information which include a unique reference code that a website transfers to your device to store and sometimes track information about you. A number of cookies we use last only for the duration of your web session and expire when you close your browser. Other cookies are used to remember you when you return to the Site and will last for longer. Cookies cannot be used to run programs or deliver viruses to your computer. They are uniquely assigned to you and can only be read by a Web server in the domain that issued the cookie.

We may use cookies to:

  • remember that you have used the Site before; this means we can identify the number of unique visitors we receive to different parts of the Site. This allows us to make sure we have enough capacity for the number of users that we get and make sure that the Site runs fast enough;
  • remember your login session so you can move from one page to another within the Site;
  • store your preferences or your user name and password so that you do not need to input these every time you visit the Site;
  • customise elements of the layout and/or content of the pages of Site for you;
  • record activity on our Sites so that we understand how you use our Sites enabling us to better tailor our content, services and marketing to your needs;
  • collect statistical information about how you use the Site so that we can improve the Site; and
  • gather information about the pages on the Site that you visit, and also other information about other websites that you visit, so as to place you in a “market segment”. This information is only collected by reference to the IP address that you are using, but does include information about the county and city you are in, together with the name of your internet service provider. This information is then used to place interest-based advertisements on the Site which it is believed will be relevant to your market segment. For more information about this type of interest based advertising, and about how to turn this feature off please visit www.youronlinechoices.co.uk. (Please email us at cookies@euromoneyplc.com if you have any queries about cookies)

Some of the cookies used by our Sites are set by us, and some are set by third parties who are delivering services (such as interest based advertising directed at your market segment) on our behalf.

To see a list of the cookies and similar technologies used on this Site and instructions on how to turn them on and off click here. (Please email us at cookies@euromoneyplc.com if you have any queries about cookies)

Most web browsers automatically accept cookies but, if you prefer, you can change your browser to prevent that or to notify you each time a cookie is set. You can also learn more about cookies in general by visiting www.allaboutcookies.org which includes additional useful information on cookies and how to block cookies using different types of browser. Please note however, that by blocking, deleting or turning off cookies used on the Site you may not be able to take full advantage of the Site.

Email tracking: So that we can better understand our users' needs, we track responses to our emails - for example, to see which links are the most popular in newsletters, and to log and follow up responses to our marketing messages. To do this, we use pixel GIFs, also known as "pixel tags" - these are small image files that are placed within the body of our email messages. They enable us to tell if a message has been opened and to track click-throughs on links within the message.
Any other purposes for which Euromoney wishes to use your personal data will be notified to you and your personal data will not be used for any such purpose without obtaining your prior consent.

Consents and opt-outs

You can give your consent to or opt out of particular uses of your data as indicated above by:

  • Indicating at the point on the relevant Site where personal data is collected;
  • Informing us by email, post or phone; or
  • Updating your preferences on the applicable Site;

For turning cookies and similar technologies on and off, see the information in paragraph 5 above.

Disclosures

Information collected at one Site may be shared between Euromoney Institutional Investor plc, Institutional Investor Inc. and other group companies for the purposes listed above.

Your personal data may also be sold to other companies in the form of lists and directories, but only after permission from you in accordance with the provisions above.

We may also disclose your personal data to other third parties, including, without limitation, professional advisers, or governmental or State institutions or regulatory authorities, where necessary in order to exercise or defend legal rights or where required by law.

We may transfer, sell or assign any of the information described in this policy to third parties as a result of a sale, merger, consolidation, change of control, transfer of assets or reorganisation of our business.

Public forums, message boards and blogs

Some of our Sites make message boards, blogs or other facilities for user generated content available and users can participate in these facilities. Any information that is disclosed in these areas becomes public information and you should always be careful when deciding to disclose your personal information.

Transfers outside the EEA

Services on the Internet are accessible globally so collection and transmission of personal data is not always limited to one country. Euromoney Institutional Investor plc may transfer your personal data, for the purposes listed above, to other group companies, service providers or other third parties which may be located in countries outside the European Economic Area, whose laws may not give the level of protection to personal data as within the UK. This will include transfers to Institutional Investor Inc. in the US (and Institutional Investor Inc. will collect some data directly from you, in relation to the Sites which it operates) and to third parties who provide us with email and marketing services. Where we conduct any transfers we will take all steps reasonably necessary to ensure that your data is treated securely and in accordance with this Privacy Statement.

Confidentiality and Security of Your Personal Data

We are committed to keeping the data you provide us secure and will take reasonable precautions to protect your personal data from loss, misuse or alteration.

The transmission of information via the internet is not completely secure. Although we will do our best to protect your personal data, we cannot guarantee the security of your data transmitted to our Site; any transmission is at your own risk. Once we have received your information, we will use strict procedures and security features described above to try to prevent unauthorised access.

We have implemented information security policies, rules and technical measures to protect the personal data that we have under our control from:

  • unauthorised access
  • improper use or disclosure
  • unauthorised modification
  • unlawful destruction or accidental loss

All our employees, contractors and data processors (i.e. those who process your personal data on our behalf, for the purposes listed above), who have access to, and are associated with the processing of your personal data, are obliged to keep the information confidential and not use it for any other purpose than to carry out the services they are performing for us.

We also give you the option of using a secure transmission method to send us personal data identifiers, such as credit card details and bank account number.

How to Access, Update and Erase your Personal Information

If you wish to know whether we are keeping personal data about you, or if you have an enquiry about our privacy policy or your personal data held by us, in relation to any of the Sites, you can contact the Data Protection Officer via:

  • Postal mail to this address: Data Protection Officer, Euromoney Institutional Investor plc, Nestor House, Playhouse Yard, London EC4V 5EX, UK
  • Telephone: +44 (0)20 7779 8600
  • Email: dataprotectionofficer@euromoneyplc.com

Upon request, we will provide you with a readable copy of the personal data which we keep about you. We may require proof of your identity and may charge a small fee (not exceeding the statutory maximum fee that can be charged) to cover administration and postage.

Euromoney allows you to challenge the data that we hold about you and, where appropriate in accordance with applicable laws, you may have your personal information:

  • erased
  • rectified or amended
  • completed

Changes to this Privacy Statement

We will occasionally update this Privacy Statement to reflect new legislation or industry practice, group company changes and customer feedback. We encourage you to review this Privacy Statement periodically to be informed of how we are protecting your personal data.

This Privacy Statement was last updated in April 2012.

This email already exists, please use "Forgot Password" page to reset a password for an existing account.
(Click "Reset Password" button below and email with password reset instruction will be emailed to you.)

Reset Password